Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,985 | -20,840 | -54,225 | -27,466 | -8,141 |
| Depreciation Amortization | -281 | -771 | 857 | 2,569 | 370 |
| Accounts receivable | -900 | N/A | N/A | N/A | N/A |
| Other Working Capital | -873 | -462 | -831 | 647 | -2,317 |
| Other Operating Activity | 2,683 | 2,041 | 33,029 | 2,005 | 1,265 |
| Operating Cash Flow | $-19,356 | $-20,032 | $-21,170 | $-22,245 | $-8,823 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,363 | 10,102 | 32,516 | -54,836 | -7,257 |
| PPE Investments | N/A | N/A | -285 | -60 | -20 |
| Net Acquisitions | N/A | N/A | -3,320 | N/A | N/A |
| Other Investing Activity | -130 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $13,233 | $10,102 | $28,911 | $-54,896 | $-7,277 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 68 | 476 | 43 | 85,524 | 18,728 |
| Other Financing Activity | -274 | -91 | -267 | -248 | -148 |
| Financing Cash Flow | $-206 | $385 | $-224 | $85,276 | $18,580 |
| Exchange Rate Effect | -55 | -16 | -10 | N/A | N/A |
| Beginning Cash Position | 22,593 | 32,154 | 24,647 | 16,512 | 14,032 |
| End Cash Position | 16,209 | 22,593 | 32,154 | 24,647 | 16,512 |
| Net Cash Flow | $-6,384 | $-9,561 | $7,507 | $8,135 | $2,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,356 | -20,032 | -21,170 | -22,245 | -8,823 |
| Capital Expenditure | N/A | N/A | -285 | -60 | -20 |
| Free Cash Flow | -19,356 | -20,032 | -21,455 | -22,305 | -8,843 |